Relative bioavailability of different valproic acid formulations.

G Franke, Werner Siegmund, E Diletti, Eberhard Scheuch, Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), M Zschiesche

PubMed

December 1, 1995

Cited by 3

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

|New England Journal of Medicine|2022|2.2k

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

|Blood|2018|421

COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients

|Infection|2020|246

Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with <b><i>Pneumocystis jirovecii</i></b> Pneumonia

|Respiration|2018|200

Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV

|HIV Medicine|2020|166